Abstract
Background: The American Heart Association has classified obesity as a major modifiable risk factor for coronary artery disease, but its relationship with age at presentation with acute myocardial infarction (AMI) is poorly documented.
Hypothesis: The study was undertaken to evaluate the impact of obesity on age at presentation, and on in‐hospital morbidity and mortality in patients with AMI.
Methods: Our analysis includes a consecutive series of 906 Olmsted County patients (mean age 67.7 years, 51% male) admitted with AMI to the Mayo Clinic Coronary Care Unit (CCU). The patients were entered into the Mayo CCU Database, a prospective registry of data pertaining to patients admitted to the Mayo Clinic CCU with AMI. Age at AMI occurrence and in‐hospital morbidity and mortality were noted.
Results: Obese patients (body mass index [BMI] >30) with AMI were significantly younger than patients with AMI in the overweight (BMI 25–30) and normal‐weight (BMI <30) groups (62.3 ± 13.1 vs. 66.9 ± 13.2 and 72.9 ± 13.4, respectively, p < 0.001). Obesity and overweight status were associated with male gender, diabetes mellitus, hypercholesterolemia, and smoking history; however, after multivariate adjustment for these risk factors, excess weight and premature AMI remained significantly associated. Compared with normal‐weight patients, overweight patients presenting with AMI were 3.6 years younger (p < 0.001, confidence interval [CI] 1.9–5.4) and obese patients 8.2 years younger (p < 0.001, CI 6.2–10.1). No significant increase in in‐hospital morbidity and mortality was seen.
Conclusion: In this population‐based study, overweight and obese status are independently associated with the premature occurrence of AMI, but not with an increased incidence of in‐hospital complications.
Keywords: obesity, acute myocardial infarction, mortality, coronary artery disease, age
Full Text
The Full Text of this article is available as a PDF (674.4 KB).
References
- 1. Anderson KM, Wilson PWF, Odell PM, Kannel WB: An updated coronary risk profile: A statement for health professionals. Circulation 1991. 33: 356 [DOI] [PubMed] [Google Scholar]
- 2. Lew EA, Garfinkel L: Variations in mortality by weight among 75,000 men and women. J Chron Dis 1979; 32: 563–576 [DOI] [PubMed] [Google Scholar]
- 3. Garcia Palmierie MR, Costos R, Schiffman J, Colon AA, Torres R, Nazario E: Interrelationship of serum lipids with relative weight, blood glucose and physical activity. Circulation 1972; 45: 829–836 [DOI] [PubMed] [Google Scholar]
- 4. Manson JE, Willet WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, Hennekens CH, Speizer FE: Body weight and mortality among women. N Engl J Med 1995; 333: 677–685 [DOI] [PubMed] [Google Scholar]
- 5. Garrison RJ, Castelli WP: Weight and thirty‐year mortality of men in the Framingham Study. Ann Intern Med 1985; 103: 1595–1607 [DOI] [PubMed] [Google Scholar]
- 6. Rabkin SW, Mathewson FA, Hsu PH: Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26‐year observation period: The Manitoba Study. Am J Cardiol 1997; 39: 452–458 [DOI] [PubMed] [Google Scholar]
- 7. Rimm EB, Stampfer MJ, Giovannucci E, Ascherio A, Spiegelman D, Colditz GA, Willet WC: Body size and fat distribution as predictors of coronary heart disease among middle‐aged and older US men. Am J? Epidemiol 1995; 141: 1117–1127 [DOI] [PubMed] [Google Scholar]
- 8. Negri E, Santoro L D'Avanzo B, Nobili A, La Vecchia C: Body mass and acute myocardial infarction. Prev Med 1992; 21: 292–301 [DOI] [PubMed] [Google Scholar]
- 9. Negri E, La Vecchia C, Franzosi MG, Tognoni G, on behalf of the GISSI‐EFRIM Investigators : Attributable risks for nonfatal myocardial infarction in Italy. Prev Med 1995; 24: 603–609 [DOI] [PubMed] [Google Scholar]
- 10. Kooner JS, Baliga RR, Wilding J, Crook D, Packard CJ, Banks LM, Peart S, Aitman TJ, Scott J: Abdominal obesity, impaired non‐esterified fatty acid suppression, and insulin mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Art Thromb Vase Biol 1998; 18: 1021–1026 [DOI] [PubMed] [Google Scholar]
- 11. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW: Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999; 341: 1097–1105 [DOI] [PubMed] [Google Scholar]
- 12. Eckel RH, for the Nutrition Committee : Obesity and heart disease. A statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 1997; 96: 3248–3250 [DOI] [PubMed] [Google Scholar]
- 13. Eckel RH, Krauss RM, for the AHA Nutrition Committee, American Heart Association : Call to action: Obesity as a major risk factor for coronary heart disease. Circulation 1998; 97: 2099–2100 [DOI] [PubMed] [Google Scholar]
- 14. Gillum RF, Fortmann SP, Prineas RJ, Kottke TE: WHO criteria for diagnosis of acute myocardial infarction. Am Heart J 1984; 108: 150–158 [DOI] [PubMed] [Google Scholar]
- 15. Killip T, Kimball JT: Treatment of myocardial infarction in a coronary care unit. A two‐year experience with 250 patients. Am J Cardiol 1967; 20: 457–464 [DOI] [PubMed] [Google Scholar]
- 16. Leibson CL O'Brien PC, Atkinson E, Palumbo PJ, Melton U III: Relative contributions of incidence and survival to increasing prevalence of adult‐onset diabetes mellitus: A population‐based study. AmJ Epidemiol 1997; 146: 12–22 [DOI] [PubMed] [Google Scholar]
- 17. Van Itallie TB: Health implications of overweight and obesity in the United States. Ann Intern Med 1985; 103: 983–988 [DOI] [PubMed] [Google Scholar]
- 18. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL: Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. J Am Med Assoc 1994; 272 lpar;3): 205–211 [DOI] [PubMed] [Google Scholar]
- 19. International Obesity Task Force : About obesity. 1998; HRAvailable://obesite.chaire.ulaval.cal/IOTF.htm
- 20. Reddy KS, Yusuf S: Emerging epidemic of cardiovascular disease in developing countries. Circulation 1998; 97: 596–601 [DOI] [PubMed] [Google Scholar]
- 21. Krauss RM, Winston M, Fletcher BJ, Grundy SM: Obesity: Impact on cardiovascular disease. Circulation 1998; 98: 1472–1476 [PubMed] [Google Scholar]
- 22. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH: Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med 1997: 337( 13):869–873 [DOI] [PubMed] [Google Scholar]
- 23. Bao W, Srinivasan SR, Valdez R, Greenlund KJ, Wattigney WA, Berenson GS: Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: The Bogalusa Heart Study. J Am Med Assoc 1997; 278 lpar;21): 1749–1754 [PubMed] [Google Scholar]
- 24. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL: The effect of age on the association between body mass index and mortality. N Engl J Med 1998: 338 lpar;1): 1–7 [DOI] [PubMed] [Google Scholar]
- 25. Chisholm DJ, Campbell LV, Kraegen EW: Pathogenesis of the insulin resistance syndrome (syndrome X). Clin Exp Pharmacol Physiol 1997: 24(9–10):782–784 [DOI] [PubMed] [Google Scholar]
- 26. Lundgren CH, Brown SL, Nordt TK, Sobel BE, Fujii S: Elaboration of type‐1 plasminogen activator inhibitor from adipocytes: A potential pathogenetic link between obesity and cardiovascular disease. Circulation 1996: 93 lpar;1): 106–110 [DOI] [PubMed] [Google Scholar]
- 27. Juhan‐Vague I, Alessi MC: PAI‐1, obesity, insulin resistance and risk of cardiovascular events. Thromb Haemost 1997: 78 lpar;1): 656–660 [PubMed] [Google Scholar]
- 28. Vague P, Juhan‐Vague I, Aillaud MF, Badier C, Viard R, Alessi MC, Collen D: Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. Metabolism 1986; 35: 250–253 [DOI] [PubMed] [Google Scholar]
- 29. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Calliff RM, Ross AM: Clinical predictors of early infarct‐related artery patency following thrombolytic therapy: Importance of body weight, smoking history, infarct‐related artery and choice of thrombolytic regimen: The GUSTO‐I experience. Global Utilization of Streptokinase and t‐PA for Occluded Coronary Arteries. J Am Coll Cardiol 1998; 32: 641–647 [DOI] [PubMed] [Google Scholar]
- 30. Karagounis LA, Anderson JL, Sorensen SG, Moreno FL: Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM‐3 investigators. Am J Cardiol 1994: 73 lpar;1): 16–22 [DOI] [PubMed] [Google Scholar]
- 31. Jeppesen J, Hein HO, Suadicani P, Gyntelberg F: Triglyceride concentration and ischemic heart disease. An eight‐year follow‐up in the Copenhagen Male Study. Circulation 1998; 97: 1029–1036 [DOI] [PubMed] [Google Scholar]
- 32. Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity : Weighing the Options: Criteria for Evaluating Weight‐Management Programs. Washington, DC: National Academy Press, 1995. [PubMed] [Google Scholar]
- 33. Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C: Prospective study of intentional weight loss and mortality in never‐smoking overweight US white women aged 40–64 years. Am J Epidemiol 1995: 141: 1128–1141 [DOI] [PubMed] [Google Scholar]
- 34. Ristow M, Muller‐Wieland D, Pfeiffer A, Krone W, Khan R: Obesity associated with a mutation in a genetic regulator of adipocyte differentation. N Engl J Med 1998; 339: 953–959 [DOI] [PubMed] [Google Scholar]